Who Expert Committee on Specifications for Pharmaceutical Preparations Thirty-ninth Report

This report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. Important topics were addressed, such as regulatory guidance on interchangeability of medicines, fix-dose combinations: how to regulate them, new guidance in the area of good manufacturing practices (GMP) and stability testing and counterfeit medicines. In addition some 12 new monographs for antiretrovirals, 6 new ones on TB drugs, including 2-, 3- and 4-fixed-dose preparations, as well as monographs for antimalarial medicines are discussed in detail. Seven new specifications for antiretrovirals were adopted. The report also includes newly International Chemical Reference Substances for the series of artemisinin derivatives.WHO Expert Committee on Specifications for Pharmaceutical Preparations is the author of 'Who Expert Committee on Specifications for Pharmaceutical Preparations Thirty-ninth Report', published 2005 under ISBN 9789241209298 and ISBN 9241209291.